AREG and breast carcinoma: Among all types of tumors, GPR81 is mainly expressed in breast cancer, especially cells positive for the estrogen receptor (ER), where it increases the production of proangiogenic amphiregulin through a PI3K/Akt/cAMP-dependent pathway [55].